News
-
-
PRESS RELEASE
DocMorris launches private placement of approx. CHF 100 million Convertible Bonds due 2031 to finance early repurchase of Convertible Bonds 2028
DocMorris AG launches CHF 100 million Convertible Bonds private placement to finance early repurchase of Convertible Bonds 2028, optimizing balance sheet and funding costs -
PRESS RELEASE
BioVersys reports half-year 2026 results: BV100 pivotal RIV-TARGET trial actively recruiting, alpibectir Phase 2b/c underway, operations funded into 2028
BioVersys reports half-year 2026 results: BV100 pivotal RIV-TARGET trial actively recruiting, alpibectir Phase 2b/c underway, operations funded into 2028 -
PRESS RELEASE
Medacta Group SA: Medacta Group SA reports above-market revenue growth of 9.7% in constant currency1 with a robust adjusted EBITDA margin of 27.8% in c.c.1 in H1 2026
Medacta Group SA reports above-market revenue growth of 9.7% in constant currency with a robust adjusted EBITDA margin of 27.8% in H1 2026. The company attributes growth to innovation and geographical expansion -
-
-
-
-
PRESS RELEASE
The Western Investment Company of Canada Limited Announces Intention to Commence Normal Course Issuer Bid
The Western Investment Company of Canada Limited announces a normal course issuer bid to repurchase 5% of its common shares. The bid, subject to TSXV approval, aims to enhance shareholder value -
![Logo of [UNKNOWN]](https://logos.symex.be/img/.jpg)
